WGS Stock Analysis: Buy, Sell, or Hold?
WGS - GeneDx Holdings Corp. Class A Common Stock
$60.74
3.65 (6.39%)
▲
5d:
-15.8%
30d:
-23.8%
90d:
-54.6%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 29, 2026
29d
Smart Money Accumulation
WGS is down 16.0% this week, but smart money is accumulating calls. Top strike: $72.5 2026-05-15 with 21 OI. Call ratio: 77% View Scanner →
Strength: 10.0/10
Get Alerted When WGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: WGS is down 15.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: WGS is down 15.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$100.08
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$62.14
2.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WGS is currently trading at $60.74, which is considered oversold relative to its 30-day fair value range of $71.21 to $87.48. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.8) compared to its historical average (185.5). Remarkably, the market is currently pricing in an annual earnings decline of 46.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, WGS is in a strong downtrend. Immediate support is located at $58.28, while resistance sits at $78.67. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $156.67 (+174.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, WGS is in a strong downtrend. Immediate support is located at $58.28, while resistance sits at $78.67. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $156.67 (+174.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$71.21 -
$87.48
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Protect Your Profits
Holding WGS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.4%)
- BULLISH: Trading 174.4% below Wall St target ($156.67)
- WARNING: Recommendation downgraded due to -15.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$71.21 -
$87.48
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$58.28
Resistance Level
$78.67
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.77
Wall Street Target
$156.67
(+174.4%)
Revenue Growth (YoY)
26.5%
Profit Margin
-4.9%
Valuation Discount vs History
-46.9% cheaper
PE vs Historical
27.8 vs 185.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-46.9%
(market-implied from PE analysis)
1-Year Target
$51.38
(-10%)
2-Year Target
$46.24
(-19%)
3-Year Target
$41.62
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→186)
$277.99
(+387%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.8, Growth: 145.1%)
$192.68
(+238%)
Base:
(SPY PE: 22.4, Growth: 145.1%)
$155.41
(+172%)
Bear:
(PE: 19.0, Growth: 145.1%)
$132.10
(+131%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.8 to 185.5
Stabilization Target:
$381.33
(+567.9%)
PE Expansion Potential:
+567.9%
Share & Embed Analysis
Last updated: March 30, 2026 11:45 AM ET
Data refreshes hourly during market hours. Next update: 12:45 PM
Data refreshes hourly during market hours. Next update: 12:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WGS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Feeley
SELL
5706 shares
2026-03-16
Katherine Stueland
SELL
17179 shares
2026-03-16
Keith A Meister
BUY
140026 shares
2026-03-05
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 58 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 60 HOLD |
Advanced WGS Option Strategies
Professional options setups generated by AI based on today's WGS price and gamma walls.
